lutetium has been researched along with scandium in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Savoie, L; Tuchweber, B | 1 |
| Cann, CE; Prussin, SG | 1 |
| MAGNUSSON, G | 1 |
| Li, HZ; Pei, MS; Zhai, DT; Zhang, J | 1 |
| Anderson, MR; Balch, AL; Cai, T; Dorn, HC; Ge, Z; Gibson, HW; Olmstead, MM; Wang, X; Xu, L; Zuo, T | 1 |
| Antunes, I; Bilewicz, A; Majkowska, A; Neves, M | 1 |
| Cai, T; Champion, H; Dorn, HC; Fu, W; Fuhrer, T; Gibson, HW; Harich, K; Reid, JE; Shu, C; Slebodnick, C; Xu, L | 1 |
| Antipov, O; Brignon, A; Moncorgé, R; Petermann, K; Soulard, R; Zinoviev, A | 1 |
| Osuna, S; Poblet, JM; Rodríguez-Fortea, A; Solà, M; Swart, M; Valencia, R | 1 |
| Bunka, M; Fischer, C; Müller, C; Reber, J; Schibli, R; Türler, A; Zhernosekov, K | 1 |
| Ahmadzadehfar, H; Bundschuh, RA; Eppard, E; Essler, M; Gaertner, FC; Khawar, A; Kürpig, S; Meisenheimer, M; Roesch, F; Sinnes, JP | 1 |
| Ahn, SH; Boros, E; Chapman, KW; Chen, Z; Cingoranelli, SJ; Cirri, A; Johnson, CJ; Koller, AJ; Lapi, SE; Loveless, CS; Vaughn, BA; Yang, Y | 1 |
| Battan, S; Bracke, A; De Loose, J; De Meester, I; Moon, ES; Rösch, F; Van der Veken, P; Van Rymenant, Y | 1 |
| Boros, E; Cingoranelli, SJ; Lapi, SE; Loveless, CS; Schlyer, D; Vaughn, BA | 1 |
14 other study(ies) available for lutetium and scandium
| Article | Year |
|---|---|
Rare earth metals and soft-tissue calcification.
Topics: Animals; Calcinosis; Dysprosium; Erbium; Holmium; Injections, Intravenous; Lutetium; Polymyxins; Rats; Scandium; Skin; Spleen; Thulium | 1968 |
Possible parathyroid imaging using Ga-67 and other aluminum analogs.
Topics: Animals; Gallium Radioisotopes; Lutetium; Male; Parathyroid Glands; Radioisotopes; Radionuclide Imaging; Rats; Scandium | 1980 |
THE BEHAVIOR OF CERTAIN LANTHANONS IN RATS.
Topics: Cerium; Chemical and Drug Induced Liver Injury; Dysprosium; Erbium; Europium; Gadolinium; Hepatitis; Hepatitis A; Histocytochemistry; Holmium; Injections; Injections, Intravenous; Kidney; Lanthanum; Liver; Lutetium; Metabolism; Neodymium; Praseodymium; Promethium; Radioisotopes; Rats; Research; Samarium; Scandium; Terbium; Thulium; Toxicology; Ytterbium | 1963 |
[Determination of ten trace rare earth elements in the sample by atomic emission spectrometry].
Topics: Barium Sulfate; Buffers; Carbon; Cerium; Dysprosium; Electrodes; Gadolinium; Lanthanum; Lutetium; Metals, Rare Earth; Neodymium; Praseodymium; Reference Standards; Reproducibility of Results; Samarium; Scandium; Spectrophotometry, Atomic; Strontium; Sulfates; Terbium; Ytterbium | 2005 |
Structure and enhanced reactivity rates of the D5h Sc3N@C80 and Lu3N@C80 metallofullerene isomers: the importance of the pyracylene motif.
Topics: Computer Simulation; Crystallography, X-Ray; Cyclization; Electrochemistry; Fullerenes; Isomerism; Kinetics; Lutetium; Models, Chemical; Models, Molecular; Molecular Structure; Organometallic Compounds; Oxazolidinones; Scandium; Time Factors; Trityl Compounds | 2006 |
Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy.
Topics: Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Imidazoles; Lutetium; Pain Management; Radioisotopes; Scandium; Zoledronic Acid | 2009 |
Highly regioselective derivatization of trimetallic nitride templated endohedral metallofullerenes via a facile photochemical reaction.
Topics: Crystallography, X-Ray; Fullerenes; Lutetium; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen Compounds; Organometallic Compounds; Photochemical Processes; Scandium; Spectrophotometry, Ultraviolet; Substrate Specificity | 2008 |
Nonlinear spectroscopic properties of Yb3+-doped sesquioxides Lu2O3 and Sc2O3.
Topics: Light; Lutetium; Materials Testing; Nonlinear Dynamics; Scandium; Spectrum Analysis; Ytterbium | 2010 |
Full exploration of the Diels-Alder cycloaddition on metallofullerenes M3N@C80 (M = Sc, Lu, Gd): the D(5h) versus I(h) isomer and the influence of the metal cluster.
Topics: Cyclization; Fullerenes; Gadolinium; Isomerism; Kinetics; Lutetium; Metals; Models, Molecular; Scandium | 2012 |
Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Topics: Animals; Beta Particles; Chelating Agents; Cyclotrons; Feasibility Studies; Female; Folic Acid; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; KB Cells; Lutetium; Mice; Positron-Emission Tomography; Radiochemistry; Radioisotopes; Scandium | 2013 |
Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.
Topics: Aged; Carcinoma; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Neoplasm Metastasis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Scandium | 2018 |
Homologous Structural, Chemical, and Biological Behavior of Sc and Lu Complexes of the Picaga Bifunctional Chelator: Toward Development of Matched Theranostic Pairs for Radiopharmaceutical Applications.
Topics: Chelating Agents; Coordination Complexes; Ligands; Lutetium; Molecular Structure; Precision Medicine; Radiopharmaceuticals; Scandium | 2021 |
In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA
Topics: Acetates; Azepines; Endopeptidases; Fibroblasts; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Lutetium; Membrane Proteins; Positron Emission Tomography Computed Tomography; Quinine; Radioisotopes; Radiopharmaceuticals; Scandium; Serine Endopeptidases | 2021 |
Evaluation of
Topics: Animals; Chelating Agents; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Mice; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Scandium; Tissue Distribution | 2021 |